SCHEMBL6413630

SCHEMBL6413630

CCOC(=O)C1C(C)C1COCc1ccc(-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NAAA Q02083 4/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KDM4E B2RXH2 1/20 0.38
EPHX1 P07099 1/20 0.38
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6406896 0.92 FABP7 (0.43) L3MBTL1KDM4ETSHR
SCHEMBL6410192 0.87 NAAA (0.42) NAAAEPHX1NPC1RAB9A
SCHEMBL6414765 0.85 NAAA (0.43) NAAAHRH3EPHX1TSHRNPC1
SCHEMBL6406976 0.84 PPARA (0.41) L3MBTL1NAAA
SCHEMBL6407087 0.84 FABP7 (0.45) KDM4ETSHRNPC1RAB9A
SCHEMBL6408048 0.80 EPHX1 (0.45) NAAAHRH3EPHX1TSHR
SCHEMBL6407675 0.79 POLB (0.42) TSHR
SCHEMBL6412514 0.79 CA12 (0.48) ATML3MBTL1NAAAEPHX1
SCHEMBL6408832 0.78 RXRA (0.35) NAAA
SCHEMBL20517351 0.77 FABP7 (0.44) L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 ATM 3047/4885L3MBTL1 2735/4885NAAA 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.